
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded otic solution containing gentamicin sulfate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing gentamicin are listed in solution, injection, ointment and cream forms. None of the FDA-approved gentamicin products is for use in the ear.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Gentamicin is an aminoglycoside antibiotic, commonly compounded into otic drops, nasal irrigations and sprays, bladder irrigations, topical creams and sterile injections.
Gentamicin is a broad-spectrum aminoglycoside antibiotic. It binds the bacterial 30S ribosome so the cell makes faulty proteins, which kills the bacterium; it is active against many aerobic gram-negative organisms such as Pseudomonas aeruginosa, E. coli and Klebsiella and against some staphylococci, but not against anaerobes, viruses or fungi. Manufactured products include gentamicin sulfate injection, FDA-approved for serious infections caused by susceptible organisms including sepsis and infections of the urinary, respiratory and gastrointestinal tracts, skin and bone; gentamicin sulfate cream, approved for primary and secondary bacterial skin infections; and ophthalmic drops and ointment for eye infections. Prescribers order gentamicin compounded when they want an ear drop, nasal or sinus rinse, bladder irrigation or wound preparation that no manufacturer makes, a different concentration, or a combination with a steroid or other antibiotic. Compounded preparations are not FDA-approved and require a prescription.
The injection label carries a boxed warning for kidney damage, hearing and balance damage that can be permanent, and nerve toxicity including numbness, twitching and seizures; risk is higher with kidney impairment, dehydration, older age, high doses or long courses. Systemic gentamicin should not be combined with other kidney- or ear-damaging drugs such as other aminoglycosides, vancomycin or cisplatin, or with strong diuretics such as furosemide, and it can cause muscle weakness in people with myasthenia gravis or those receiving muscle relaxants during anesthesia. It is contraindicated with aminoglycoside allergy. Topical cream can cause irritation, sensitization and overgrowth of non-susceptible organisms, and burn patients can absorb it systemically. Pregnancy: aminoglycosides cross the placenta and can cause fetal harm, including deafness reported with streptomycin. Breastfeeding: gentamicin passes into milk poorly and is minimally absorbed; watch for diarrhea, thrush or diaper rash. Talk to your prescriber or pharmacist right away about ringing in the ears, hearing change, dizziness or reduced urination.
Gentamicin is a bactericidal aminoglycoside with concentration-dependent killing and a postantibiotic effect; bacterial uptake is oxygen dependent, so anaerobes are resistant. It is minimally absorbed from the gut, is 0 to 30 percent protein bound, penetrates the CNS and most cells poorly, and is eliminated unchanged by glomerular filtration with at least 70 percent recovered in urine within 24 hours in normal renal function. Half-life tracks creatinine clearance and is shortened by fever, anemia and severe burns; the drug accumulates in renal cortex. Labeled indications: gentamicin sulfate injection (serious infections by susceptible Pseudomonas, Proteus, E. coli, Klebsiella-Enterobacter-Serratia, Citrobacter and Staphylococcus species; neonatal sepsis), gentamicin sulfate cream (primary and secondary pyodermas, infected dermatoses, burns and wounds), ophthalmic solution and ointment (conjunctivitis, keratitis). Prescribers have ordered compounded gentamicin otic drops with polymyxin, neomycin and hydrocortisone in alcohol for otitis externa (US Pharmacist 2009) and gentamicin-containing bladder irrigation (IJPC 2004). Dosing is per prescriber. Monitoring for systemic use: peak and trough serum levels for courses beyond about 6 days or in high-risk patients, serum creatinine or BUN and urinalysis during therapy, serial audiograms when feasible, and neuromuscular status in myasthenia or perioperatively. Not a controlled substance.
Wash your hands. Warm the bottle in your hand for a few minutes, since cold drops can cause dizziness. Lie on your side or tilt your head so the affected ear faces up. Pull the ear up and back (back and down for a young child) and place the number of drops on your label into the canal without touching the dropper tip to your ear. Stay in position for a few minutes. Recap and wash your hands. Do not use drops that have changed color or turned cloudy.
Otic solutions are aqueous or glycerin based. Under USP <795>, a preserved aqueous solution usually carries a beyond-use date of up to 35 days; an unpreserved one 14 days refrigerated; a nonaqueous solution may carry up to 180 days. Follow the storage line on your label, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place drops into affected ear(s)